Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lepor

Showing results (401-410 of 457) with videos related to

Pageof 46
Sort By:
Oncotarget|October 3, 2015
Cigarette side-stream smoke lung and bladder carcinogenesis: inducing mutagenic acrolein-DNA adducts, inhibiting DNA repair and enhancing anchorage-independent-growth cell transformationHyun-Wook Lee, Hsiang-Tsui Wang, Mao-wen Weng, et al.
Plos One|June 5, 2013
Functional domains of androgen receptor coactivator p44/Mep50/WDR77and its interaction with Smad1Yirong Li, Liantian Tian, Martin Ligr, et al.
The Journal of Urology|October 7, 2020
Application of the PRECISION Trial Biopsy Strategy to a Contemporary Magnetic Resonance Imaging-Targeted Biopsy Cohort-How Many Clinically Significant Prostate Cancers are Missed?Zachary Feuer, Xiaosong Meng, Andrew B Rosenkrantz, et al.
Frontiers in Oncology|February 27, 2024
High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiationJonathan W Lischalk, Meredith Akerman, Michael C Repka, et al.
Urology|September 4, 2015
Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy StrategiesNeil Mendhiratta, Xiaosong Meng, Andrew B Rosenkrantz, et al.
The Journal of Urology|June 24, 2015
Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk StratificationNeil Mendhiratta, Andrew B Rosenkrantz, Xiaosong Meng, et al.
Urology|April 1, 1996
A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter studyP Narayan, J Trachtenberg, H Lepor, et al.
Reviews in Cardiovascular Medicine|April 30, 2019
Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic ReviewAaron Y Kluger, Kristen M Tecson, Clay M Barbin, et al.
BJU International|December 2, 2011
Testosterone in prostate cancer: the Bethesda consensusBob Djavan, James Eastham, Leonard Gomella, et al.
Molecular Endocrinology (Baltimore, Md.)|April 30, 2011
LEF1 identifies androgen-independent epithelium in the developing prostateXinyu Wu, Garrett Daniels, Ellen Shapiro, et al.
Pageof 46

Showing results (401-410 of 457) with videos related to

Sort By:
Pageof 46
Oncotarget|October 3, 2015
Cigarette side-stream smoke lung and bladder carcinogenesis: inducing mutagenic acrolein-DNA adducts, inhibiting DNA repair and enhancing anchorage-independent-growth cell transformationHyun-Wook Lee, Hsiang-Tsui Wang, Mao-wen Weng, et al.
Plos One|June 5, 2013
Functional domains of androgen receptor coactivator p44/Mep50/WDR77and its interaction with Smad1Yirong Li, Liantian Tian, Martin Ligr, et al.
The Journal of Urology|October 7, 2020
Application of the PRECISION Trial Biopsy Strategy to a Contemporary Magnetic Resonance Imaging-Targeted Biopsy Cohort-How Many Clinically Significant Prostate Cancers are Missed?Zachary Feuer, Xiaosong Meng, Andrew B Rosenkrantz, et al.
Frontiers in Oncology|February 27, 2024
High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiationJonathan W Lischalk, Meredith Akerman, Michael C Repka, et al.
Urology|September 4, 2015
Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy StrategiesNeil Mendhiratta, Xiaosong Meng, Andrew B Rosenkrantz, et al.
The Journal of Urology|June 24, 2015
Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk StratificationNeil Mendhiratta, Andrew B Rosenkrantz, Xiaosong Meng, et al.
Urology|April 1, 1996
A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter studyP Narayan, J Trachtenberg, H Lepor, et al.
Reviews in Cardiovascular Medicine|April 30, 2019
Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic ReviewAaron Y Kluger, Kristen M Tecson, Clay M Barbin, et al.
BJU International|December 2, 2011
Testosterone in prostate cancer: the Bethesda consensusBob Djavan, James Eastham, Leonard Gomella, et al.
Molecular Endocrinology (Baltimore, Md.)|April 30, 2011
LEF1 identifies androgen-independent epithelium in the developing prostateXinyu Wu, Garrett Daniels, Ellen Shapiro, et al.
Pageof 46